[Remote] Manager, Supply Chain Management at Abata Therapeutics

Remote

Abata Therapeutics Logo
Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
BiotechnologyIndustries

Requirements

  • Experience with material management of cGMP materials (Cell Banks, Drug Substance, and Drug Product)
  • Experience with logistics execution and oversight of DS and DP supply
  • Experience with Demand & Operations Planning (D&OP)
  • Experience with forecasting tools for clinical supply planning
  • Experience developing packaging and supply strategies
  • Experience with vendor management and RFPs
  • Experience with SOP development

Responsibilities

  • Maintain inventory oversight of applicable drug supply
  • Support logistics execution and oversight of DS and DP supply
  • Assist with assembly of bulk devices and allocation across studies
  • Develop and execute Demand & Operations Planning (D&OP)
  • Utilize forecasting tools to develop clinical supply forecasts
  • Develop packaging and supply strategies to meet clinical study needs
  • Clearly communicate expiry requirements
  • Represent Apogee with external providers
  • Manage oversight of packaging and labeling jobs
  • Develop requests for proposals for labeling, packaging, storage, and distribution
  • Review vendor invoices and provide input for accruals and budget
  • Coordinate US and international distribution and logistics for clinical studies
  • Drive development of Interactive Response Technology (IRT) user requirement specifications and acceptance testing

Skills

Key technologies and capabilities for this role

Supply Chain ManagementMaterial ManagementClinical StudiesGlobal InteractionsRegulatory RequirementsSupply Chain ConfigurationTrial DesignManufacturing Availability

Questions & Answers

Common questions about this position

Is this position remote?

Yes, the position is fully remote.

What are the key responsibilities of this role?

Responsibilities include maintaining inventory oversight of cGMP materials like Cell Banks, Drug Substance, and Drug Product, supporting logistics and trade compliance, assisting with device assembly, developing Demand & Operations Planning, utilizing forecasting tools for clinical supply forecasts, and managing supply chain for clinical studies.

What is the company culture like at Apogee Therapeutics?

Apogee Therapeutics is a fast-paced, highly dynamic environment committed to building an exceptional company culture founded on C.O.R.E. values: Caring, Original, Resilient, and Egoless, where employees can shape the culture and grow professionally.

What salary or compensation does this role offer?

This information is not specified in the job description.

What kind of experience makes a strong candidate for this role?

A highly motivated and results-oriented professional with experience in end-to-end cGMP material management, supply chain for clinical studies, global interactions, forecasting tools, and cross-functional collaboration with Clinical Operations, Regulatory Affairs, Quality, and Manufacturing.

Abata Therapeutics

Develops therapies for autoimmune diseases

About Abata Therapeutics

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.

Cambridge, MassachusettsHeadquarters
2021Year Founded
$184.8MTotal Funding
EARLY_VCCompany Stage
BiotechnologyIndustries
11-50Employees

Risks

Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.
Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.
Rising clinical trial costs pose financial risks to Abata's pipeline progression.

Differentiation

Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.
Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.
Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.

Upsides

Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.
FDA's accelerated approval pathways may expedite Abata's clinical trials.
Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.

Land your dream remote job 3x faster with AI